The purpose of the weight-loss study is to characterize the effect of LGG supplementation on the relative abundance of phyla in the gut microbiota of patients undergoing gastric bypass and sleeve gastrectomy surgery, and to elucidate a relationship between the gut microbiota pattern and the degree of weight-loss post-surgery. The investigators hypothesize that LGG administration will result in a "leaner" pattern of gut microbiota that will lead to higher weight loss at 3 months post-surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
18
LGG will be administered orally for 44 days
placebo will be administered daily for 44 days
Tufts Medical Center Weight and Wellness Center
Boston, Massachusetts, United States
Weight Loss
Time frame: 4 months
Percentage of Bacteria Phyla
We will specifically look at the percentages of different bacterial phyla in the stool and intestine
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.